Patents by Inventor David Pellman

David Pellman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating a meiotic kinesin-associated disease
    Patent number: 9645136
    Abstract: The invention provides methods of treating a meiotic kinase-associated disease, preferably the meiotic kinase HSET, by administering an inhibitor of the meiotic kinase. Preferably, the disease is associated with the presence of supernumerary centrosomes, such as cancer. Methods of inhibiting the growth of a tumor cell by contacting the cell with an inhibitor of a meiotic kinase, preferably HSET, are also provided. Screening methods for identifying inhibitors of the meiotic kinase HSET are also provided. Methods of selecting subjects for treatment with an inhibitor of a meiotic kinase, such as HSET, are also provided.
    Type: Grant
    Filed: January 7, 2015
    Date of Patent: May 9, 2017
    Assignee: DANA-FARBER CANCER INSTITUTE, INC.
    Inventor: David Pellman
  • METHODS OF TREATING A MEIOTIC KINESIN-ASSOCIATED DISEASE
    Publication number: 20150111786
    Abstract: The invention provides methods of treating a meiotic kinase-associated disease, preferably the meiotic kinase HSET, by administering an inhibitor of the meiotic kinase. Preferably, the disease is associated with the presence of supernumerary centrosomes, such as cancer. Methods of inhibiting the growth of a tumor cell by contacting the cell with an inhibitor of a meiotic kinase, preferably HSET, are also provided. Screening methods for identifying inhibitors of the meiotic Kinase HSET are also provided. Methods of selecting subjects for treatment with an inhibitor of a meiotic kinase, such as HSET, are also provides.
    Type: Application
    Filed: January 7, 2015
    Publication date: April 23, 2015
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventor: David Pellman
  • Methods of treating a meiotic kinesin associated disease
    Patent number: 8962592
    Abstract: The invention provides methods of treating a meiotic kinase-associated disease, preferably the meiotic kinase HSET, by administering an inhibitor of the meiotic kinase. Preferably, the disease is associated with the presence of supernumerary centrosomes, such as cancer. Methods of inhibiting the growth of a tumor cell by contacting the cell with an inhibitor of a meiotic kinase, preferably HSET, are also provided. Screening methods for identifying inhibitors of the meiotic kinase HSET are also provided. Methods of selecting subjects for treatment with an inhibitor of a meiotic kinase, such as HSET, are also provided.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: February 24, 2015
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventor: David Pellman
  • METHODS OF TREATING A MEIOTIC KINESIN ASSOCIATED DISEASE
    Publication number: 20140106344
    Abstract: The invention provides methods of treating a meiotic kinase-associated disease, preferably the meiotic kinase HSET, by administering an inhibitor of the meiotic kinase. Preferably, the disease is associated with the presence of supernumerary centrosomes, such as cancer. Methods of inhibiting the growth of a tumor cell by contacting the cell with an inhibitor of a meiotic kinase, preferably HSET, are also provided. Screening methods for identifying inhibitors of the meiotic kinase HSET are also provided. Methods of selecting subjects for treatment with an inhibitor of a meiotic kinase, such as HSET, are also provided.
    Type: Application
    Filed: December 11, 2013
    Publication date: April 17, 2014
    Applicant: Dana-Faber Cancer Institute, Inc.
    Inventor: David Pellman
  • Methods of treating a meiotic kinesin associated disease
    Patent number: 8629118
    Abstract: The invention provides methods of treating a meiotic kinase-associated disease, preferably the meiotic kinase HSET, by administering an inhibitor of the meiotic kinase. Preferably, the disease is associated with the presence of supernumerary centrosomes, such as cancer. Methods of inhibiting the growth of a tumor cell by contacting the cell with an inhibitor of a meiotic kinase, preferably HSET, are also provided. Screening methods for identifying inhibitors of the meiotic kinase HSET are also provided. Methods of selecting subjects for treatment with an inhibitor of a meiotic kinase, such as HSET, are also provided.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: January 14, 2014
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventor: David Pellman
  • METHODS OF TREATING A MEIOTIC KINESIN ASSOCIATED DISEASE
    Publication number: 20110190374
    Abstract: The invention provides methods of treating a meiotic kinase-associated disease, preferably the meiotic kinase HSET, by administering an inhibitor of the meiotic kinase. Preferably, the disease is associated with the presence of supernumerary centrosomes, such as cancer. Methods of inhibiting the growth of a tumor cell by contacting the cell with an inhibitor of a meiotic kinase, preferably HSET, are also provided. Screening methods for identifying inhibitors of the meiotic kinase HSET are also provided. Methods of selecting subjects for treatment with an inhibitor of a meiotic kinase, such as HSET, are also provided.
    Type: Application
    Filed: May 28, 2009
    Publication date: August 4, 2011
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventor: David Pellman